Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

Animalcare Group delisted from AIM after takeover by Charterhouse subsidiary

The shares of Animalcare Group were removed from trading on the AIM of the London Stock Exchange on Wednesday morning after CCP PAW 2 Limited — a 100% subsidiary of funds managed/advised by Charterhouse Capital Partners — acquired the company via a scheme of arrangement under Part 26 of the Companies Act 2006. The scheme took effect on Wednesday; Animalcare plans to convert into a private limited company. Financial and legal advisers on the transaction included Rothschild & Co, Stifel Nicolaus Europe, Panmure Liberum, Allen & Overy and Squire Patton Boggs. » Mere på de.investing.com
Animalcare Group issues 967,954 new shares after option exercise

Following court approval of the takeover scheme and the exercise of outstanding options, Animalcare Group has issued 967,954 new ordinary shares. The exercise followed the takeover announcement by CCP PAW 2 Limited (Charterhouse) and rendered the options vested and exercisable under Rule 15 of the Takeover Code. The new shares are expected to be admitted to trading on AIM on Tuesday at around 08:00; issued share capital rises to 70,013,899 shares of 20 pence each. CEO Jennifer Winter received 468,797 shares (total 569,447; 0.81%) and CFO Christopher Brewster 188,384 shares (total 473,897; 0.68%). » Mere på de.investing.com
JPMorgan increases stake in Animalcare Group to 6.356%

JPMorgan Chase & Co. has increased its voting stake in the Animalcare Group to 6.356% and now holds 4,388,686 voting rights. The position comprises 6.351% direct share voting rights via J.P. Morgan Securities PLC and 0.005% through cash-settled equity swaps with maturities to November 2026 and July 2027. The notification was made in accordance with UK disclosure requirements. » Mere på de.investing.com

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2025 har ANIMALCARE GROUP allerede udloddet 0,0595 € i udbytte. Den seneste udlodning fandt sted i november 2025.

Virksomhedstal

I det seneste kvartal havde ANIMALCARE GROUP en omsætning på 51,98 mio. € og et nettoresultat på 2,08 mio. €

(EUR)	december 2025	YoY
Omsætning	51,98 mio.	-
Bruttofortjeneste	25,51 mio.	-
Nettoresultat	2,08 mio.	-
EBITDA	9,3 mio.	-

Fundamentale data

Nøgletal	Værdi
Markedsværdi	269,37 mio. €
Antal aktier	69,05 mio.
Højeste/laveste i 52 uger	3,96 € - 2,52 €
Udbytteafkast	0,64 %
Udbytte TTM	0,0249 €
Beta	0,67
P/E (PE Ratio)	45,39
PEG (PEG Ratio)	-0,53
K/I (PB Ratio)	2,02
P/S (PS Ratio)	2,60

Virksomhedsprofil

Animalcare Group plc entwickelt, verkauft und vertreibt zugelassene Tierarzneimittel und Identifizierungsprodukte sowie Dienstleistungen für Haus- und Nutztiere und für den Veterinärmarkt für Pferde. Darüber hinaus ist das Unternehmen im Großhandel und Vertrieb von Tierarzneimitteln tätig. Das Unternehmen beliefert Kunden in Belgien, den Niederlanden, dem Vereinigten Königreich, Deutschland, Spanien, Italien, Portugal, anderen europäischen Ländern, Asien, dem Nahen Osten, Afrika und international. Die Animalcare Group plc wurde 1972 gegründet und hat ihren Sitz in York, Vereinigtes Königreich.